Rationale and design of the International verapamil SR/Trandolapril Study (INVEST) : An internet-based randomized trial in coronary artery disease patients with hypertension
- Author
- PEPINE, C. J1 ; HANDBERG-THURMOND, E1 ; MARKS, R. G2 ; CONLON, M2 ; COOPER-DEHOFF, R3 ; VOLKERS, P2 ; ZELLIG, P4
[1] Division of Cardiovascular Medicine, University of Florida, College of Medicine, Gainesville, Florida, United States
[2] Department of Biostatistics, University of Florida, College of Medicine, Gainesville, Florida, United States
[3] Research Pharmacy Division of Shands Hospital, University of Florida, College of Medicine, Gainesville, Florida, United States
[4] Knoll AG BASF Pharma, Ludwigshafen, Germany
The Invest Investigators - Source
Journal of the American College of Cardiology. 1998, Vol 32, Num 5, pp 1228-1237 ; ref : 55 ref
- CODEN
- JACCDI
- ISSN
- 0735-1097
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Elsevier Science, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Aralkylamine Association morbide Aténolol Cardiopathie coronaire Chimiothérapie Conception Efficacité traitement Etude comparative Homme Hydrochlorothiazide Hypertension artérielle Population Pronostic Thiazide Traitement Trandolapril Vérapamil Antagoniste calcium Antihypertenseur Appareil circulatoire pathologie Bloquant β-adrénergique Diurétique Inhibiteur angiotensin converting enzyme
- Keyword (en)
- Aralkylamine Concomitant disease Atenolol Coronary heart disease Chemotherapy Design Treatment efficiency Comparative study Human Hydrochlorothiazide Hypertension Population Prognosis Thiazide Treatment Trandolapril Verapamil Calcium antagonist Antihypertensive agent Cardiovascular disease Beta blocking agent Diuretic ACE inhibitor
- Keyword (es)
- Aralquilamina Asociación morbosa Atenolol Cardiopatía coronaria Quimioterapia Diseño Eficacia tratamiento Estudio comparativo Hombre Hidroclorotiazida Hipertensión arterial Población Pronóstico Tiazida Tratamiento Trandolapril Verapamilo Antagonista calcio Antihipertensivo Aparato circulatorio patología Bloqueador β-adrenérgico Diurético Inhibidor angiotensin converting enzyme
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F05 Antihypertensive agents
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1581329
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/S0735-1097(98)00423-9 
https://dx.doi.org/10.1016/S0735-1097(98)00423-9
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(98)00423-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:173:\"Rationale and design of the International verapamil SR\/Trandolapril Study (INVEST) : An internet-based randomized trial in coronary artery disease patients with hypertension\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"32\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1228\";s:8:\"\u0000*\u0000epage\";s:4:\"1237\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PEPINE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:20:\"HANDBERG-THURMOND, E\";i:1;s:11:\"MARKS, R. G\";i:2;s:9:\"CONLON, M\";i:3;s:16:\"COOPER-DEHOFF, R\";i:4;s:10:\"VOLKERS, P\";i:5;s:9:\"ZELLIG, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:173:\"Rationale and design of the International verapamil SR\/Trandolapril Study (INVEST) : An internet-based randomized trial in coronary artery disease patients with hypertension\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(98)00423-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:173:\"Rationale and design of the International verapamil SR\/Trandolapril Study (INVEST) : An internet-based randomized trial in coronary artery disease patients with hypertension\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"32\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1228\";s:8:\"\u0000*\u0000epage\";s:4:\"1237\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PEPINE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:20:\"HANDBERG-THURMOND, E\";i:1;s:11:\"MARKS, R. G\";i:2;s:9:\"CONLON, M\";i:3;s:16:\"COOPER-DEHOFF, R\";i:4;s:10:\"VOLKERS, P\";i:5;s:9:\"ZELLIG, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:173:\"Rationale and design of the International verapamil SR\/Trandolapril Study (INVEST) : An internet-based randomized trial in coronary artery disease patients with hypertension\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(98)00423-9\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(98)00423-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:173:\"Rationale and design of the International verapamil SR\/Trandolapril Study (INVEST) : An internet-based randomized trial in coronary artery disease patients with hypertension\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"32\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1228\";s:8:\"\u0000*\u0000epage\";s:4:\"1237\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PEPINE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:20:\"HANDBERG-THURMOND, E\";i:1;s:11:\"MARKS, R. G\";i:2;s:9:\"CONLON, M\";i:3;s:16:\"COOPER-DEHOFF, R\";i:4;s:10:\"VOLKERS, P\";i:5;s:9:\"ZELLIG, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:173:\"Rationale and design of the International verapamil SR\/Trandolapril Study (INVEST) : An internet-based randomized trial in coronary artery disease patients with hypertension\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0735-1097(98)00423-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:173:\"Rationale and design of the International verapamil SR\/Trandolapril Study (INVEST) : An internet-based randomized trial in coronary artery disease patients with hypertension\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:2:\"32\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1228\";s:8:\"\u0000*\u0000epage\";s:4:\"1237\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PEPINE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:20:\"HANDBERG-THURMOND, E\";i:1;s:11:\"MARKS, R. G\";i:2;s:9:\"CONLON, M\";i:3;s:16:\"COOPER-DEHOFF, R\";i:4;s:10:\"VOLKERS, P\";i:5;s:9:\"ZELLIG, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:173:\"Rationale and design of the International verapamil SR\/Trandolapril Study (INVEST) : An internet-based randomized trial in coronary artery disease patients with hypertension\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
